Highlights
The Group achieved strong 2025 financial results, driven by growth in Surgical, Woundcare, and a full-year contribution from Peters Surgical. With ongoing efficiencies and upcoming product approvals, the Board expects continued growth through to 2028.
Total Group revenue
£0.0m
+29% (2024: £177.5m) · Change at constant currency +29%
Adjusted EBITDA
£0.0m
+24% (2024: £40.2m)
Adjusted EBITDA margin
0.0%
-0.8pp (2024: 22.6%)
Adjusted profit before tax
£0.0m
+15% (2024: £29.4m)
Adjusted profit before tax margin
0.0%
-1.8pp (2024: 16.6%)
Adjusted diluted earnings per share
0.00p
+12% (2024: 10.45p)
Uniting expertise,unlocking efficiencies
We enter 2026 with a unified purpose and mission and a bold new corporate identity to represent where we are heading. In a world where the needs of patients and partners continue to evolve, our renewed identity captures the impact we strive to make every day and reflects our ambitions -
Confident. Unified. Future Focused.
Our purpose: We unite expertise to improve patients’ lives
Our strategy
Driving long-term, sustainable growth by delivering better patient outcomes for tissue healing
portfolio
Expanding a streamlined medical device portfolio
footprint
Marketed through an increased geographic footprint and direct sales function
expertise
Manufactured with excellence and efficiency through AMS's own specialist facilities
People and culture
Sustainability
Message from our Chairman and Chief Executive Officer
well positioned
to continue building momentum
Guided by our new purpose, our strategy is delivering through an expanded portfolio, improving efficiencies and growing global presence, as we enter 2026 well positioned to continue building momentum.
Chris Meredith
Chief Executive Officer
Strategy in action
portfolio
AMS has established and continues to expand a diverse mix of products with exposure to a range of surgical markets, specialising in tissue-healing technology.
Environment Social Governance (ESG)
ESG model
Reinforcing a sustainable and ethical approach in everything we do
Our Purpose helps us to improve patients' lives by aligning and enabling ESG-related initiatives that support responsible decision-making and long-term value creation for our stakeholders.
planet
"We are committed to minimising any negative impact on the environment and upholding the highest standards of corporate responsibility."
Eddie Johnson
Chief Financial Officer and ESG Lead